Clinical Trial Results: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating a combination of ascorbic acid with NAB-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer; study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma
• Pancreatic Metastases

Drugs mentioned

• Ascorbic acid (Vitamin C)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel protein-bound (paclitaxel protein-bound)

Snippet

Sponsor: HonorHealth Research Institute | Conditions: Pancreatic Cancer, Pancreas Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-07-23